🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 82% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
Other Combinations Product Type
82% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin C
100 mg (167% DV)
25 IU (83% DV)
✅ 1.1× RDA — within safe limits 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 16.75mg UL 1000mg
25 mg (125% DV)
✅ 1.8× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 25mg UL 35mg
5 mg (250% DV)
📊 3.8× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 5mg UL 100mg
400 mcg (100% DV)
✅ Within RDA (1.0× RDA of 0.4 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.4mg UL 1.0mg
5 mcg (83% DV)
✅ 2.1× RDA — within safe limits 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.005mg
400 mg (100% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 400mg
📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)
This product: 60mg UL 1200mg
📊 Market median: 333.0mg (166 products) 📚 9 studies (Tier A: 0, B: 2)
This product: 100mg
500 mg
📊 Market median: 500.0mg (861 products) 📚 60 studies (Tier A: 4, B: 13)
This product: 500mg
📊 Market median: 60.0mg (94 products) 📚 13 studies (Tier A: 0, B: 7)
This product: 250mg
Horsechestnut seed extract
100 mg
500 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 500mg
📊 Market median: 260.0mg (249 products) 📚 156 studies (Tier A: 4, B: 61)
This product: 50mg
📊 Market median: 100.0mg (284 products) 📚 10 studies (Tier A: 0, B: 4)
This product: 5mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 50mg
Cayenne
25 mg

Other Ingredients

Magnesium Stearate Cellulose Vegetable Stearin Dicalcium Phosphate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (71% of products) No Claim (2% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, adults take three (3) tablets daily with meals, or as directed by a health care professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

🧪 Formulation Notes

Contains No Added dairy, wheat, corn, soy, preservatives, artificial colors or flavors.

Additional Information

Store in a cool, dry place and away from direct light.

#10029

For Support of Cardiovascular Health

Our standardized extracts are produced by European companies under strict European quality control standards.

QUALITY AND POTENCY GUARANTEED

"We Make It Better..."

Product Details

DSLD Entry Date 2013-02-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 18838
Data Updated 2026-04-11

Research Evidence

11 Research Sources
49 Avg Quality Score
8 Rct
3 Meta Analysis
B Hawthorn extract for treating chronic heart failure
Meta Analysis The Cochrane database of systematic reviews 2008
B The combination of hawthorn extract and camphor significantly increases blood pressure: A meta-analysis and systematic review
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2019
C Effect of vitamin C and hawthorn beverage formula on blood pressure and oxidative stress in heat-exposed workers: a cluster-randomized controlled trial
Rct Asia Pacific journal of clinical nutrition 2024
C Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials
Meta Analysis The American journal of medicine 2003
C Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial
Rct European journal of heart failure 2009
C The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure
Rct European journal of heart failure 2008
C [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)]
Rct Fortschritte der Medizin 1996
C Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II
Rct Phytomedicine : international journal of phytotherapy and phytopharmacology 2001
C Effects of a Scutellaria baicalensis/Crataegus laevigata, magnesium and chromium supplement on stressed individuals: A randomised, double-blind, placebo-controlled, crossover trial.
Rct Journal of psychopharmacology (Oxford, England)
C [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure]
Rct Arzneimittel-Forschung 2001
View all evidence for Hawthorn →

Compare Similar Products

View all Hawthorn products →